About Us
History
The International Serum Industry Association was formed in June 2006 with a specific focus on the Serum Industry. Since that time the scope of the Association has broadened to include all animal derived products for use in the multibillion dollar life science and biomedical sectors.
The Association does not include food applications or human derived materials within its sphere of influence.
Mission Statement
ISIA shall establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and animal derived products supply industry.
Our primary focus will be on safety and safe use of serum and blood derived products through proper origin traceability and truth in labeling, and appropriate standardization and oversight.
We will also work to educate stakeholders on the scientific foundation of the safe use of serum and animal derived products.
Board of Directors
| Name | Position | Company |
| Steve Doelger |
Chairman |
SAFC Biosciences |
| Skip Wrape | Vice-Chairman | Animal Technologies |
| Karla White |
Director | Millipore |
| Allen Burgenson |
Director | Lonza |
| Elizabeth Meixner |
Director | Moregate Biotech |
| Rainer Burian |
Director | PAA Laboratories |
| Ole Nielsen |
Director | BioWest |
| Jim Crean | Director | Life Technologies |
| Don Myers | Director | Central Biomedia |
| Kent Treichler | Director | SeraCare |
| Peter Haeusl | Director | Biomin |
Officers
| Name | Position | Company |
| Rosemary Versteegen |
CEO* |
ISIA |
| Stephen Judd |
CFO* |
Axenia BioLogix |
| Jenny Murray | Secretary* | Sera Lab Ltd |
| *Non-voting positions |
Global Network
ISIA has developed a worldwide network of contacts with regulatory agencies, other associations and interested parties. We continue to proactively develop this resource for our membership. Click here to view a schematic of our global contacts